Literature DB >> 16720983

Chloroquine-resistant Plasmodium falciparum local strain in Taiz Governorate, Republic of Yemen.

Hussien O Alkadi1, Mohamed T Al-Maktari, Majed A Nooman.   

Abstract

BACKGROUND: The emergence of Plasmodium falciparum resistance to widely used antimalarial drugs such as chloroquine has made malaria control and treatment much more difficult. In Yemen, 60% of the total population live in malarious areas. The problem of chloroquine resistance in Yemen is gradually worsening since the detection of first indigenous cases of P. falciparum resistance to chloroquine in 1989.
METHODS: In a cross-sectional malariometric parasitic survey, 447 Yemeni children were enrolled from two selected districts (Hethran and Al-mafatch) representing Taiz Governorate. Duplicate thin and thick blood smears were prepared, stained with Giemsa stain and examined microscopically. Fifty-six students satisfied all criteria of the WHO for the assessment of P. falciparum response to chloroquine using a 7-day in vivo test.
RESULTS: Out of 447 examined slides, 83 cases (100%) were found with falciparum malaria. The overall malaria parasite rate in Taiz Governorate was 18.6%, a prevalently mesoendemic condition. The obtained results of the 7-day in vivo study revealed that out of 83 P. falciparum cases who completed the study period, 56 cases did not respond to the standard dose of chloroquine, i.e. the overall resistance rate was 16.1%. The prevalence of chloroquine resistance was higher in the Hethran district (19.4%) compared with 10.0% in the Al-mafatch district. The majority had an RI resistance level.
CONCLUSION: Chloroquine resistance of the local strain of P. falciparum was recorded in all studied districts in Taiz Governorate. This calls for an urgent revision of the current malaria treatment policy which still considers chloroquine as the first-line drug for treatment of uncomplicated P. falciparum malaria. To assess the magnitude of the problem, these districts could be the basis of future sentinel posts for continuous monitoring of chloroquine resistance in the whole country.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16720983     DOI: 10.1159/000093592

Source DB:  PubMed          Journal:  Chemotherapy        ISSN: 0009-3157            Impact factor:   2.544


  12 in total

1.  Distribution of drug resistance genotypes in Plasmodium falciparum in an area of limited parasite diversity in Saudi Arabia.

Authors:  Saad M Bin Dajem; Hissa M Al-Farsi; Zainab S Al-Hashami; Adel Ali H Al-Sheikh; Ahmed Al-Qahtani; Hamza A Babiker
Journal:  Am J Trop Med Hyg       Date:  2012-05       Impact factor: 2.345

2.  Human malaria in the highlands of Yemen.

Authors:  A M Al-Mekhlafi; H M Al-Mekhlafi; M A K Mahdy; A A Azazy; M Y Fong
Journal:  Ann Trop Med Parasitol       Date:  2011-04

3.  Molecular epidemiology of Plasmodium species prevalent in Yemen based on 18 s rRNA.

Authors:  Abdulsalam Mq Al-Mekhlafi; Mohammed Ak Mahdy; Ahmed A Azazy; Mun Yik Fong
Journal:  Parasit Vectors       Date:  2010-11-19       Impact factor: 3.876

4.  Effect of Khat (Catha edulis) Use on the Bioavailability, Plasma Levels and Antimalarial Activity of Chloroquine.

Authors:  Faiza H Issa; Molhem Al-Habori; Michael L Chance
Journal:  Sultan Qaboos Univ Med J       Date:  2016-05-15

5.  High frequency of Plasmodium falciparum chloroquine resistance marker (pfcrt T76 mutation) in Yemen: an urgent need to re-examine malaria drug policy.

Authors:  Abdulsalam M Al-Mekhlafi; Mohammed A K Mahdy; Hesham M Al-Mekhlafi; Ahmed A Azazy; Mun Yik Fong
Journal:  Parasit Vectors       Date:  2011-05-27       Impact factor: 3.876

6.  Genetic diversity of Plasmodium falciparum and distribution of drug resistance haplotypes in Yemen.

Authors:  Salama Al-Hamidhi; Mohammed A K Mahdy; Zainab Al-Hashami; Hissa Al-Farsi; Abdulsalam M Al-mekhlafi; Mohamed A Idris; Albano Beja-Pereira; Hamza A Babiker
Journal:  Malar J       Date:  2013-07-15       Impact factor: 2.979

7.  Sustained efficacy of artesunate-sulfadoxine-pyrimethamine against Plasmodium falciparum in Yemen and a renewed call for an adjunct single dose primaquine to clear gametocytes.

Authors:  Wahib M Atroosh; Hesham M Al-Mekhlafi; Georges Snounou; Adel Al-Jasari; Hany Sady; Nabil A Nasr; Yee-Ling Lau; Johari Surin
Journal:  Malar J       Date:  2016-05-27       Impact factor: 2.979

8.  The suitability of P. falciparum merozoite surface proteins 1 and 2 as genetic markers for in vivo drug trials in Yemen.

Authors:  Nazeh M Al-abd; Mohammed A K Mahdy; Abdulsalam M Q Al-Mekhlafi; Georges Snounou; Nazia B Abdul-Majid; Hesham M Al-Mekhlafi; Mun Y Fong
Journal:  PLoS One       Date:  2013-07-04       Impact factor: 3.240

9.  Malaria in Hadhramout, a southeast province of Yemen: prevalence, risk factors, knowledge, attitude and practices (KAPs).

Authors:  Omar A A Bamaga; Mohammed A K Mahdy; Rohela Mahmud; Yvonne A L Lim
Journal:  Parasit Vectors       Date:  2014-07-29       Impact factor: 3.876

10.  Entomological aspects and the role of human behaviour in malaria transmission in a highland region of the Republic of Yemen.

Authors:  Samira M A Al-Eryani; Louise Kelly-Hope; Ralph E Harbach; Andrew G Briscoe; Guy Barnish; Ahmed Azazy; Philip J McCall
Journal:  Malar J       Date:  2016-03-01       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.